These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36197412)

  • 21. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus.
    Iwabuchi A; Kamoda T; Saito M; Nozue H; Izumi I; Hirano T; Sumazaki R
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1093-7. PubMed ID: 23817599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus.
    Barchetta I; Ciccarelli G; Barone E; Cimini FA; Ceccarelli V; Bertoccini L; Sentinelli F; Tramutola A; Del Ben M; Angelico F; Baroni MG; Lenzi A; Cavallo MG
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1087-1094. PubMed ID: 31431395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion.
    Patarrão RS; Duarte N; Coelho I; Ward J; Ribeiro RT; Meneses MJ; Andrade R; Costa J; Correia I; Boavida JM; Duarte R; Gardete-Correia L; Medina JL; Pell J; Petrie J; Raposo JF; Macedo MP; Penha-Gonçalves C
    Diabetologia; 2022 May; 65(5):861-871. PubMed ID: 35190847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
    Birnbaum Y; Bajaj M; Yang HC; Ye Y
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis.
    Min SH; Yoon JH; Hahn S; Cho YM
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dipeptidyl peptidase 4 serum activity and concentration are increased in women with polycystic ovary syndrome.
    Blauschmidt S; Greither T; Lampe K; Köller S; Kaltwaßer P; Behre HM
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):741-747. PubMed ID: 28799235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes.
    Nargis T; Kumar K; Ghosh AR; Sharma A; Rudra D; Sen D; Chakrabarti S; Mukhopadhyay S; Ganguly D; Chakrabarti P
    Mol Metab; 2017 Nov; 6(11):1529-1539. PubMed ID: 29107298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of dipeptidyl peptidase IV polymorphism with clinicopathological characters of oral cancer.
    Chen PJ; Lu HJ; Nassef Y; Lin CW; Chuang CY; Lee CY; Chiu YW; Yang SF; Yang WE
    J Oral Pathol Med; 2022 Sep; 51(8):730-737. PubMed ID: 35880802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes.
    Al-Aissa Z; Rosta K; Hadarits O; Harreiter J; Zóka A; Bancher-Todesca D; Patócs A; Kiss K; Sármán B; Pusztai P; Sziller I; Rigó J; Rácz K; Somogyi A; Kautzky-Willer A; Firneisz G
    Eur J Clin Invest; 2015 Feb; 45(2):196-203. PubMed ID: 25556541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of subclinical atherosclerosis in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study.
    Zheng TP; Liu YH; Yang LX; Qin SH; Liu HB
    Atherosclerosis; 2015 Oct; 242(2):580-8. PubMed ID: 26318108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased shedding dipeptidyl peptidase 4 from membrane in Hashimoto's thyroiditis.
    Xu W; Liu Y; Cheng X; Huang N; Hou N; Wang H; Han F; Han X; Sun X
    Int Immunopharmacol; 2020 Apr; 81():106315. PubMed ID: 32086131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in China.
    Zheng T; Liu H; Qin L; Chen B; Zhang X; Hu X; Xiao L; Qin S
    Metabolism; 2018 Oct; 87():105-112. PubMed ID: 29572131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
    Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
    Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network.
    Gao Q; Zhang W; Li T; Yang G; Zhu W; Chen N; Jin H
    Sci Rep; 2022 Jan; 12(1):188. PubMed ID: 34996987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.
    Romacho T; Sell H; Indrakusuma I; Roehrborn D; Castañeda TR; Jelenik T; Markgraf D; Hartwig S; Weiss J; Al-Hasani H; Roden M; Eckel J
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E590-E599. PubMed ID: 31891536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
    Wang N; Yang T; Li J; Zhang X
    Diabetes Metab Syndr Obes; 2019; 12():1513-1526. PubMed ID: 31692532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DPP4 Inhibitors in the Management of Hospitalized Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Rabizadeh S; Tavakoli Ardakani MA; Mouodi M; Bitaraf M; Shab-Bidar S; Esteghamati A; Nakhjavani M
    Adv Ther; 2020 Sep; 37(9):3660-3675. PubMed ID: 32671686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DPP4 genetic variants influence baseline prostate-specific antigen levels: the J-MICC study.
    Higashibata T; Naito M; Mori A; Ozawa N; Furuta M; Tsuchiya R; Koyama E; Morita E; Kawai S; Okada R; Yin G; Wakai K; Hamajima N
    Nagoya J Med Sci; 2013 Feb; 75(1-2):73-80. PubMed ID: 23544270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS study.
    Penfornis A; Bourdel-Marchasson I; Quere S; Dejager S
    Diabetes Metab; 2012 Dec; 38(6):550-7. PubMed ID: 22996038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a
    Yazbeck R; Jaenisch S; Squire M; Abbott CA; Parkinson-Lawrence E; Brooks DA; Butler RN
    Sci Rep; 2019 Mar; 9(1):4906. PubMed ID: 30894647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.